BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 2986808)

  • 21. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive breast cancer: Part 1. Ductal carcinoma in situ--incidence, presentation, guidelines to treatment.
    Swain SM
    Oncology (Williston Park); 1989 Mar; 3(3):25-31; discussion 40, 42, 44 passim. PubMed ID: 2561880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
    Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma.
    Eusebi V; Foschini MP; Cook MG; Berrino F; Azzopardi JG
    Semin Diagn Pathol; 1989 May; 6(2):165-73. PubMed ID: 2548274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
    J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentric and bilateral appearance of lobular carcinoma in situ of the breast.
    Anderson JA
    Acta Pathol Microbiol Scand A; 1974 Nov; 82(6):730-4. PubMed ID: 4374873
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).
    Kluttig A; Trocchi P; Heinig A; Holzhausen HJ; Taege C; Hauptmann S; Boecker W; Decker T; Loening T; Schmidt-Pokrzywniak A; Thomssen C; Lantzsch T; Buchmann J; Stang A
    BMC Cancer; 2007 Jun; 7():100. PubMed ID: 17570833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
    Smitt MC; Horst K
    Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
    Wärnberg F; Bergh J; Zack M; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ carcinomas of the female breast. Diagnostic and therapeutic aspects with special reference to histological growth patterns. Clinical review.
    Blichert-Toft M; Andersen J; Dyreborg U
    Acta Chir Scand; 1990 Feb; 156(2):113-9. PubMed ID: 2158737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
    Reinier KS; Vacek PM; Geller BM
    Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study.
    Brogi E; Robson M; Panageas KS; Casadio C; Ljung BM; Montgomery L
    Cancer; 2003 Nov; 98(10):2170-6. PubMed ID: 14601086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lobular carcinoma in situ and intraductal carcinoma of the breast.
    Rosen PP
    Monogr Pathol; 1984; (25):59-105. PubMed ID: 6330539
    [No Abstract]   [Full Text] [Related]  

  • 39. Simultaneous bilateral cancer of the brease--evaluation of the use of a contralateral biopsy.
    Andersen LI; Muchardt O
    Acta Chir Scand; 1980; 146(6):407-9. PubMed ID: 6258365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal carcinoma of the breast.
    von Rueden DG; Wilson RE
    Surg Gynecol Obstet; 1984 Feb; 158(2):105-11. PubMed ID: 6320480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.